The signaling pathways of TGF-β and BMP are well studied, but the effectiveness of their use as either therapeutic targets or agents respectively has not been as good as expected, probably due to their complex signaling pathways and their ability to modulate not only cancer cells, but also the microenvironment. The gene discussed is TGFB1; the disease is cancer.